TD-3504

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTD-3504
Drug Alias NameTD-3504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheravance Biopharma Inc
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A